TW200617162A - Surface display vector of sars virus antigen and microorganisms transformed thereby - Google Patents

Surface display vector of sars virus antigen and microorganisms transformed thereby

Info

Publication number
TW200617162A
TW200617162A TW093136838A TW93136838A TW200617162A TW 200617162 A TW200617162 A TW 200617162A TW 093136838 A TW093136838 A TW 093136838A TW 93136838 A TW93136838 A TW 93136838A TW 200617162 A TW200617162 A TW 200617162A
Authority
TW
Taiwan
Prior art keywords
sars
surface display
virus antigen
display vector
sars virus
Prior art date
Application number
TW093136838A
Other languages
Chinese (zh)
Other versions
TWI297359B (en
Inventor
Moon-Hee Sung
Chul-Joong Kim
Chang-Min Jung
Seung-Pyo Hong
Jong-Su Lee
Jae-Chul Choi
Kwang Kim
Shunichi Kuroda
Ha-Ryoung Poo
Original Assignee
Bioleaders Corp
M D Lab
Bioleaders Japan Corp
Korea Res Inst Of Bioscience
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioleaders Corp, M D Lab, Bioleaders Japan Corp, Korea Res Inst Of Bioscience filed Critical Bioleaders Corp
Priority to TW93136838A priority Critical patent/TWI297359B/en
Publication of TW200617162A publication Critical patent/TW200617162A/en
Application granted granted Critical
Publication of TWI297359B publication Critical patent/TWI297359B/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The present invention relates to a surface expression vector of SARS coronavirus antigen containing a gene encoding an antigen of SARS inducing coronavirus and any one or two or more of genes pgsB, pgsC and pgsA encoding poly-gamma-glutamic acid synthase complex, a microorganism transformed by the surface expression vector, and a SARS vaccine comprising the microorganism. According to the present invention, it is possible to economically produce a vaccine for prevention and treatment of SARS using a recombinant strain expressing an SARS coronavirus antigen on their surface.
TW93136838A 2004-11-30 2004-11-30 Surface display vector of sars virus antigen and microorganisms transfomred thereby TWI297359B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW93136838A TWI297359B (en) 2004-11-30 2004-11-30 Surface display vector of sars virus antigen and microorganisms transfomred thereby

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW93136838A TWI297359B (en) 2004-11-30 2004-11-30 Surface display vector of sars virus antigen and microorganisms transfomred thereby

Publications (2)

Publication Number Publication Date
TW200617162A true TW200617162A (en) 2006-06-01
TWI297359B TWI297359B (en) 2008-06-01

Family

ID=45069064

Family Applications (1)

Application Number Title Priority Date Filing Date
TW93136838A TWI297359B (en) 2004-11-30 2004-11-30 Surface display vector of sars virus antigen and microorganisms transfomred thereby

Country Status (1)

Country Link
TW (1) TWI297359B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112430611A (en) * 2020-11-30 2021-03-02 华南理工大学 Optimized zearalenone degrading enzyme ZHD-P encoding gene, recombinant thallus, surface display system and application

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112430611A (en) * 2020-11-30 2021-03-02 华南理工大学 Optimized zearalenone degrading enzyme ZHD-P encoding gene, recombinant thallus, surface display system and application

Also Published As

Publication number Publication date
TWI297359B (en) 2008-06-01

Similar Documents

Publication Publication Date Title
KR100469936B1 (en) Cell Surface Expression Vector of SARS Virus Antigen and Microorganisms Transformed Thereby
CY1106334T1 (en) OPTIMIZED PAMMILA VIRUS CODING SEQUENCES
MY140829A (en) Chimeric adenoviruses for use in cancer treatment
MX2010003371A (en) Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereof.
BRPI0921758A2 (en) bifidobacterium longum
WO2005059093A3 (en) P ef-tu expression units
MX2018008135A (en) Influenza nucleic acid molecules and vaccines made therefrom.
WO2010122367A3 (en) Meganuclease variants cleaving the genomic insertion of a virus and uses thereof
WO2007062936A3 (en) Dna binding site of a transcriptional activator useful in gene expression
MA30581B1 (en) RECOMBINANT VIRAL VACCINE
SG156690A1 (en) Mammalian genes involved in infection
NZ597601A (en) Treatment and prevention of influenza
MX2007009628A (en) Replication-deficient rna viruses as vaccines.
WO2020127532A3 (en) Rna encoding a protein
WO2008133137A1 (en) Vector for gene therapy
BRPI0518109A (en) bacterial strain, nucleocapsid, vaccine preparation, method for creating a recombinant bacterium, mutant bacterium, fluorinated rna sequences and electroporation medium
TNSN07090A1 (en) Novel laccase enzyme and use thereof
WO2012135600A3 (en) Gall wasp control agents
UA90098C2 (en) Promoter of vaccinia virus
TW200617162A (en) Surface display vector of sars virus antigen and microorganisms transformed thereby
ATE464385T1 (en) N-ACETYL-(R,S)-B-AMINO ACID ACYLASE GENES
UA93658C2 (en) Cell surface glycoprotein
WO2001072977A3 (en) Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
ATE338826T1 (en) RECOMBINANT VIRAL VECTORS FOR TETRACYCLINE-REGULABLE GENE EXPRESSION
GB201018125D0 (en) Peptide

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees